Sierra Pharmaceuticals Limited., a active public limited company, was established on 14 June 1999 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397DL1999PLC100240. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.51 M.
It upholds a compliant status. Its leadership includes Veena Sharma (Director), Anil Sharma (Director), Tanuj Sharma (Director). Past directors included Ajay Gupta, Sadhana Gupta. It holds ₹9.92 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 71 Church Lanesummon Bazar Bhogal, New Delhi, Delhi.
U51397DL1999PLC100240
100240
14 June 1999
₹1.00 M
₹0.51 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sierra Pharmaceuticals Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veena Sharma | Director | 01 Aug 2008 | Current |
| Anil Sharma | Director | 14 Jun 1999 | Current |
| Tanuj Sharma | Director | 01 Aug 2008 | Current |
| Archna Sharma | Director | 14 Jun 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Sep 2009 | Past |
| Pramod Abcsdd | Director | 25 Sep 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sierra Pharmaceuticals Limited., for the financial year ended 2022, experienced significant growth in revenue, with a 23.95% increase. The company also saw a substantial improvement in profitability, with a 143.11% increase in profit. The company's net worth moved up by a moderate rise of 4.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Sierra Pharmaceuticals had a promoter holding of 98.43% and a public holding of 1.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,920,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2025 | Others | ₹0.92 M | Open |
| 09 Apr 2024 | Others | ₹5.00 M | Open |
| 08 Oct 2010 | Central Bank Of India | ₹3.50 M | Open |
| 13 Jul 2002 | State Bank Of India | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sierra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sierra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sierra Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 0.92 M with Charge ID 101082707 was registered on 29 Mar 2025. was documented.
The activity Sierra Pharmaceuticals Limited. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge with Others amounted to Rs. 5.00 M with Charge ID 100918242 was registered on 09 Apr 2024. was documented.
Progress on Sierra Pharmaceuticals Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on A charge with Central Bank Of India of Rs. 3.50 M registered on 08 Oct 2010 with Charge ID 10247508 was modified on 09 Mar 2013. was documented.
The activity A charge with Central Bank Of India amounted to Rs. 3.50 M with Charge ID 10247508 was registered on 08 Oct 2010. was completed.
The CIN of Sierra Pharmaceuticals Limited. is U51397DL1999PLC100240.
Sierra Pharmaceuticals Limited. is headquartered at 71 Church Lanesummon Bazar Bhogal, New Delhi, Delhi.
Sierra Pharmaceuticals Limited. was incorporated on 14 June 1999.
The current directors of Sierra Pharmaceuticals Limited. are
The primary industry of Sierra Pharmaceuticals Limited. is Pharma.
Sierra Pharmaceuticals Limited. is unlisted.
The authorized capital of Sierra Pharmaceuticals Limited. is ₹1.00 M, and the paid-up capital is ₹0.51 M.
The compliance status of Sierra Pharmaceuticals Limited. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX